Clinical and Translational Discovery (Dec 2022)

Clinical application of cell‐based therapies opportunities and challenges

  • Jie Gao,
  • Duojiao Wu

DOI
https://doi.org/10.1002/ctd2.110
Journal volume & issue
Vol. 2, no. 4
pp. n/a – n/a

Abstract

Read online

Abstract Immune checkpoint inhibitors or anti‐cancer immunotherapy using cellular transfer have emerged as new therapies in this field. These therapies work to overcome or alleviate tumour‐induced immunosuppression, resulting in immune‐mediated tumour clearance. Cellular therapies have the largest number of active agents and clinical trials. More targets have been explored, more trials have been opened and more patients have been recruited for trials as a result of recent advancements. In this article, we describe the latest developments and major obstacles in cell therapy for cancer treatment, starting with tumour‐infiltrating T cells.

Keywords